Stanford-StartX Fund-backed Firefly has raised $30m from investors including GV, with the capital earmarked for expansion in regional markets including New York City.

Thrive will commercialise a blood test for multiple early-stage cancers based on research at Johns Hopkins University, following a series A round backed by Blue Cross and Blue Shield Association.

Thrive will commercialise a blood test for multiple early-stage cancers based on research at Johns Hopkins University, following a series A round backed by Blue Cross and Blue Shield Association.

The digital life insurance provider has sourced $12.6m in a series A round that included RGAx and Anthemis Exponential Ventures.

Road freight documentation platform Vector has closed its Congruent Ventures-backed series A at $12m, adding $2m to the initial close reported last month.

Morse Micro, a designer of wifi chips for IoT applications, has won the support of Uniseed and the Csiro Innovation Fund in a round that brought its total to at least $20.8m.

Lenovo Capital and Incubator Group has provided $14.4m in series A funding for the augmented reality module technology developer having also led its last round.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Hyundai-backed industrial security drone developer Percepto secured funding in a USVP-led series A round that boosted its overall equity financing to nearly $28m.

UCB Ventures and Alphabet unit GV took part in the RNA-targeting gene therapy developer's first publicly disclosed funding round, which was led by Arch Venture Partners.